Rilmenidine
Tenaxum contains the active substance rilmenidine, which lowers blood pressure. The effect of the medicine lasts for 24 hours.
Tenaxum is indicated for the treatment of primary (essential) hypertension.
Before starting to take Tenaxum, the patient should discuss it with their doctor or pharmacist.
Tenaxum is not recommended for use in children and adolescents.
The patient should tell their doctor or pharmacist about all medicines they are taking or have recently taken, as well as any medicines they plan to take.
The patient should not take Tenaxum with the following medicinal product (see also section "When not to take Tenaxum"):
The patient should ensure that their doctor is informed about the use of any of the following medicines, as their combination with Tenaxum is not recommended:
The patient should ensure that their doctor is informed about the use of any of the following medicines, as special caution may be required:
antihypertensive medicines, baclofen (a medicine used to treat muscle stiffness in diseases such as multiple sclerosis), thalidomide (used in the treatment of certain cancers), pizotifen and indoramine (used in the treatment of migraine attacks).
The patient should not drink alcohol while taking Tenaxum.
This medicine is not recommended during pregnancy.
The patient should not take Tenaxum if they are breastfeeding. They should immediately inform their doctor if they are breastfeeding or plan to breastfeed.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a baby, they should consult their doctor or pharmacist before taking this medicine.
Tenaxum may affect the patient's ability to drive or use machines due to the risk of drowsiness after taking this medicine.
If the patient has been diagnosed with an intolerance to some sugars, they should contact their doctor before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet, which means it is considered "sodium-free".
This medicine should always be taken according to the doctor's instructions. If in doubt, the patient should consult their doctor or pharmacist.
Tenaxum is taken orally.
The recommended dose is 1 tablet (1 mg) per day, taken in the morning at the start of a meal.
If after one month of treatment, blood pressure values have not normalized, the doctor will increase the dose to 2 tablets (2 mg) per day (one tablet in the morning and one in the evening).
Use in children and adolescents
Tenaxum is not recommended for use in children and adolescents.
If the patient has taken too many tablets, they may experience very low blood pressure and attention disorders.
The patient should contact their doctor or pharmacist immediately.
The patient should not take a double dose to make up for a missed dose, just take the next dose as usual.
Treatment with Tenaxum should not be stopped abruptly. If it is necessary to discontinue the medicine, the dose should be gradually reduced under medical supervision.
If the patient has any further doubts about the use of this medicine, they should consult their doctor, pharmacist, or nurse.
Like all medicines, Tenaxum can cause side effects, although not everybody gets them.
If the patient experiences symptoms of bradycardia (slow heart rate), including dizziness, fainting, or fatigue, they should contact their doctor.
The following side effects have been reported:
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should inform their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
By reporting side effects, more information can be collected on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Store in a temperature below 30°C.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Tenaxum is available in packs containing 30 tablets.
For more detailed information, the patient should contact the marketing authorization holder or the parallel importer.
Les Laboratoires Servier
50, rue Carnot
92284 Suresnes cedex
France
Les Laboratoires Servier Industrie
905, Route de Saran
45520 Gidy
France
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Laboratorium Galenowe Olsztyn Sp. z o.o.
ul. Spółdzielcza 25A
11-001 Dywity
CEFEA Sp. z o.o. Sp. komandytowa
ul. Działkowa 56
02-234 Warszawa
Pharma Innovations Sp. z o. o.
ul. Jagiellońska 76
03-301 Warszawa
Marketing authorization number in the Czech Republic, the country of export: 58/477/97-C
Parallel import authorization number: 245/18
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.